Literature DB >> 22334613

Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice.

Ilse M Rood1, Jeroen K J Deegens, Jack F M Wetzels.   

Abstract

Focal segmental glomerulosclerosis (FSGS) is a common cause of steroid-resistant nephrotic syndrome in children and adults. Although FSGS is considered a podocyte disease, the aetiology is diverse. In recent years, many inheritable genetic forms of FSGS have been described, caused by mutations in proteins that are important for podocyte function. In the present commentary, we review these genetic causes of FSGS and describe their prevalence in familial and sporadic FSGS. In routine clinical practice, the decision to perform the costly DNA analysis should be based on the assessment if the results affect the care of the individual patient with respect to the evaluation of extra-renal manifestations, treatment decisions, transplantation and genetic counselling.

Entities:  

Mesh:

Year:  2012        PMID: 22334613     DOI: 10.1093/ndt/gfr771

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  48 in total

Review 1.  Glomerular diseases: FSGS.

Authors:  Bhadran Bose; Daniel Cattran
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

2.  Retrospective mutational analysis of NPHS1, NPHS2, WT1 and LAMB2 in children with steroid-resistant focal segmental glomerulosclerosis - a single-centre experience.

Authors:  Agnieszka Bińczak-Kuleta; Jacek Rubik; Mieczysław Litwin; Małgorzata Ryder; Klaudyna Lewandowska; Olga Taryma-Leśniak; Jeremy S Clark; Ryszard Grenda; Andrzej Ciechanowicz
Journal:  Bosn J Basic Med Sci       Date:  2014-05       Impact factor: 3.363

3.  A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis.

Authors:  Haiyang Yu; Mykyta Artomov; Sebastian Brähler; M Christine Stander; Ghaidan Shamsan; Matthew G Sampson; J Michael White; Matthias Kretzler; Jeffrey H Miner; Sanjay Jain; Cheryl A Winkler; Robi D Mitra; Jeffrey B Kopp; Mark J Daly; Andrey S Shaw
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

4.  A kidney-specific genome-scale metabolic network model for analyzing focal segmental glomerulosclerosis.

Authors:  Salma Sohrabi-Jahromi; Sayed-Amir Marashi; Shiva Kalantari
Journal:  Mamm Genome       Date:  2016-02-29       Impact factor: 2.957

5.  Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome.

Authors:  Svjetlana Lovric; Humphrey Fang; Virginia Vega-Warner; Carolin E Sadowski; Heon Yung Gee; Jan Halbritter; Shazia Ashraf; Pawaree Saisawat; Neveen A Soliman; Jameela A Kari; Edgar A Otto; Friedhelm Hildebrandt
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-17       Impact factor: 8.237

Review 6.  Minimal change disease and idiopathic FSGS: manifestations of the same disease.

Authors:  Rutger J Maas; Jeroen K Deegens; Bart Smeets; Marcus J Moeller; Jack F Wetzels
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

7.  Analysis of the genes responsible for steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis in Japanese patients by whole-exome sequencing analysis.

Authors:  Daisuke Ogino; Taeko Hashimoto; Motoshi Hattori; Noriko Sugawara; Yuko Akioka; Gen Tamiya; Satoshi Makino; Kentaro Toyota; Tetsuo Mitsui; Kiyoshi Hayasaka
Journal:  J Hum Genet       Date:  2015-10-15       Impact factor: 3.172

8.  A Deregulated Stress Response Underlies Distinct INF2-Associated Disease Profiles.

Authors:  Samet Bayraktar; Julian Nehrig; Ekaterina Menis; Kevser Karli; Annette Janning; Thaddäus Struk; Jan Halbritter; Ulf Michgehl; Michael P Krahn; Christian E Schuberth; Hermann Pavenstädt; Roland Wedlich-Söldner
Journal:  J Am Soc Nephrol       Date:  2020-06       Impact factor: 10.121

9.  The Incidence of Primary vs Secondary Focal Segmental Glomerulosclerosis: A Clinicopathologic Study.

Authors:  Musab S Hommos; An S De Vriese; Mariam P Alexander; Sanjeev Sethi; Lisa Vaughan; Ladan Zand; Kharmen Bharucha; Nicola Lepori; Andrew D Rule; Fernando C Fervenza
Journal:  Mayo Clin Proc       Date:  2017-10-27       Impact factor: 7.616

Review 10.  Actualizing the Benefits of Genomic Discovery in Pediatric Nephrology.

Authors:  Matthew G Sampson
Journal:  J Pediatr Genet       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.